loader
Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering 2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic acid

Menu
$ API Ref.Price (USD/KG) : 39,268Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 30GLAXOSMITHKLINE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 11117871

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-3535

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-03-13

blank

02

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 11117871

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-3535

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-03-13

blank

03

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 11117871

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-3535

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-03-13

blank

04

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 11117871

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-3535

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-03-13

blank

05

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 11117871

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-3535

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-03-13

blank

06

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 8815884

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-1238

Delist Requested :

Patent Use Description : TREATMENT OF ANEMIA DU...

Patent Expiration Date : 2027-06-22

blank

07

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 8815884

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-1238

Delist Requested :

Patent Use Description : TREATMENT OF ANEMIA DU...

Patent Expiration Date : 2027-06-22

blank

08

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 8815884

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-1238

Delist Requested :

Patent Use Description : TREATMENT OF ANEMIA DU...

Patent Expiration Date : 2027-06-22

blank

09

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 8815884

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-1238

Delist Requested :

Patent Use Description : TREATMENT OF ANEMIA DU...

Patent Expiration Date : 2027-06-22

blank

10

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

DAPRODUSTAT

US Patent Number : 8815884

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216951

Patent Use Code : U-1238

Delist Requested :

Patent Use Description : TREATMENT OF ANEMIA DU...

Patent Expiration Date : 2027-06-22

blank